{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:35:49Z","timestamp":1793770549132,"version":"4.6.1"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.05060"],"award-info":[{"award-number":["2020.05060"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.colsurfb.2022.112999","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T13:18:22Z","timestamp":1667395102000},"page":"112999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"C","title":["Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases"],"prefix":"10.1016","volume":"221","author":[{"given":"Maria In\u00eas","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2022.112999_bib1","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib2","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s11033-020-05361-2","article-title":"Biological barriers, and the influence of protein binding on the passage of drugs across them","volume":"47","author":"Wanat","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.colsurfb.2022.112999_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2020.01.005","article-title":"Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases","volume":"149","author":"Teixeira","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2022.112999_bib6","doi-asserted-by":"crossref","unstructured":"D. Vieira, L. Gamarra, Multifunctional Nanoparticles for Successful Targeted Drug Delivery across the Blood-Brain Barrier, 2018.","DOI":"10.5772\/intechopen.76922"},{"key":"10.1016\/j.colsurfb.2022.112999_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: the rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120645","article-title":"An update on actively targeted liposomes in advanced drug delivery to glioma","volume":"602","author":"Mojarad-Jabali","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001375","article-title":"Transport of polymer nanoparticles across the blood\u2013brain barrier","volume":"10","author":"Ayer","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2022.112999_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/ejnm-2014-0022","article-title":"Designing the future of nanomedicine: current barriers to targeted brain therapeutics","volume":"6","author":"Herda","year":"2014","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/nnm.16.15","article-title":"Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis","volume":"11","author":"Posadas","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2022.112999_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2022.112999_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1476-5381.2012.02103.x","article-title":"The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood\u2013brain barrier cells","volume":"167","author":"Pinz\u00f3n-Daza","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib15","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.3390\/app11199336","article-title":"Polysorbate-based drug formulations for brain-targeted drug delivery and anticancer therapy","volume":"11","author":"Ravichandran","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123108","article-title":"Approaches to CNS drug delivery with a focus on transporter-mediated transcytosis","volume":"20","author":"Abdul Razzak","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","article-title":"Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier","volume":"76","author":"Villase\u00f1or","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.sbi.2016.12.005","article-title":"Protein engineering approaches for regulating blood\u2013brain barrier transcytosis","volume":"45","author":"Goulatis","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1557\/mrs.2014.9","article-title":"Understanding nano-bio interactions to improve nanocarriers for drug delivery","volume":"39","author":"Pearson","year":"2014","journal-title":"MRS Bull."},{"key":"10.1016\/j.colsurfb.2022.112999_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119821","article-title":"Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier","volume":"589","author":"W\u00fcnsch","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12951-021-01048-3","article-title":"Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib24","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2147\/IJN.S131367","article-title":"A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells","volume":"12","author":"Liu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2010.03.024","article-title":"Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis","volume":"394","author":"Tamaru","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.colsurfb.2022.112999_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00639-1","article-title":"Transferrin-Pep63-liposomes accelerate the clearance of A\u03b2 and rescue impaired synaptic plasticity in early Alzheimer's disease models","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.colsurfb.2022.112999_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/nano8030178","article-title":"Transferrin functionalized liposomes loading dopamine HCl: development and permeability studies across an in vitro model of human blood\u2013brain barrier","volume":"8","author":"Lopalco","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib28","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","author":"Lam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2022.112999_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020065","article-title":"Methotrexate-loaded solid lipid nanoparticles: protein functionalization to improve brain biodistribution","volume":"11","author":"Muntoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib31","unstructured":"M. Si , A. Transferrin conjugated nanoemulsion system for brain delivery of antiretroviral therapy, Temple University. Libraries, 2019."},{"key":"10.1016\/j.colsurfb.2022.112999_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejps.2011.07.007","article-title":"Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas","volume":"44","author":"Chen","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib34","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1016\/j.biomaterials.2014.03.082","article-title":"Protection of SK-N-MC cells against \u03b2-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin","volume":"35","author":"Kuo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2015.12.054","article-title":"Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation","volume":"499","author":"Kuo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.msec.2018.02.004","article-title":"Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine","volume":"92","author":"Zhao","year":"2018","journal-title":"Mater. Sci. Eng.: C"},{"key":"10.1016\/j.colsurfb.2022.112999_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.colsurfb.2015.06.025","article-title":"A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease","volume":"134","author":"Meng","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2022.112999_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","article-title":"Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain","volume":"14","author":"Teixeira","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/03639045.2019.1569039","article-title":"Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement","volume":"45","author":"Karami","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/10837450.2019.1621897","article-title":"Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery","volume":"24","author":"Wu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib41","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.2147\/IJN.S214657","article-title":"The optimization design of lactoferrin loaded HupA nanoemulsion for targeted drug transport via intranasal route","volume":"14","author":"Jiang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jgm.1152","article-title":"Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter","volume":"10","author":"Xia","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cns.12580","article-title":"Use of PEGylated immunoliposomes to deliver dopamine across the blood-brain barrier in a rat model of Parkinson's disease","volume":"22","author":"Kang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.colsurfb.2022.112999_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biopha.2017.06.012","article-title":"Effect of microRNA-129-5p targeting HMGB1-RAGE signaling pathway on revascularization in a collagenase-induced intracerebral hemorrhage rat model","volume":"93","author":"Ma","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2022.112999_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/molecules22020277","article-title":"Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Loureiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2022.112999_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biomaterials.2016.07.027","article-title":"ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals","volume":"112","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1208\/s12249-018-1206-x","article-title":"IGF-II-conjugated nanocarrier for brain-targeted delivery of p11 gene for depression","volume":"20","author":"Gandhi","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2022.112999_bib48","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7150\/thno.7088","article-title":"In vivo theranostics at the peri-infarct region in cerebral ischemia","volume":"4","author":"Agulla","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymthe.2017.10.003","article-title":"Nanotherapeutics for gene modulation that prevents apoptosis in the brain and fatal neuroinflammation","volume":"26","author":"Kim","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2022.112999_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/10837450.2016.1226901","article-title":"Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines","volume":"22","author":"Gandomi","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/pharmaceutics13010038","article-title":"ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood-brain barrier","volume":"13","author":"Topal","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib53","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/acs.molpharmaceut.6b00781","article-title":"Biomimetic ApoE-reconstituted high density lipoprotein nanocarrier for blood\u2013brain barrier penetration and amyloid beta-targeting drug delivery","volume":"13","author":"Song","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib54","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1039\/C7SC00732A","article-title":"Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma","volume":"8","author":"Rajora","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib55","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S241055","article-title":"Brain targeted gold liposomes improve RNAi delivery for glioblastoma","volume":"15","author":"Grafals-Ruiz","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/anticanres.13103","article-title":"Cell-penetrating peptide-coated liposomes for drug delivery across the blood\u2013brain barrier","volume":"39","author":"Yuan","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib57","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/j.biomaterials.2014.02.031","article-title":"Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1389201017666160401144440","article-title":"Synergistic combination of doxorubicin and paclitaxel delivered by blood brain barrier and glioma cells dual targeting liposomes for chemotherapy of brain glioma","volume":"17","author":"Chen","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.actbio.2019.01.065","article-title":"Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration","volume":"87","author":"Kuo","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2022.112999_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2016.08.040","article-title":"Delivery of Copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes","volume":"512","author":"Tremmel","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib61","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.xphs.2018.07.020","article-title":"Dual functionalized 5-fluorouracil liposomes as highly efficient nanomedicine for glioblastoma treatment as assessed in an in vitro brain tumor model","volume":"107","author":"Lakkadwala","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib62","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood\u2013brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib63","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1007\/s12274-017-1561-z","article-title":"Anionic liposomes for small interfering ribonucleic acid (siRNA) delivery to primary neuronal cells: evaluation of alpha-synuclein knockdown efficacy","volume":"10","author":"Schlich","year":"2017","journal-title":"Nano Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","article-title":"A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease","volume":"277","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112999_bib65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","article-title":"Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy","volume":"132","author":"Kadari","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2022.112999_bib68","doi-asserted-by":"crossref","first-page":"CT216","DOI":"10.1158\/1538-7445.AM2014-CT216","article-title":"Abstract CT216: phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma","volume":"74","author":"Gaillard","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib69","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/acsbiomaterials.1c00555","article-title":"Glutathione liposomes carrying ceftriaxone, FK506, and nilotinib to control overexpressed dopamine markers and apoptotic factors in neurons","volume":"7","author":"Kuo","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.colsurfb.2022.112999_bib70","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","article-title":"Glioma targeting and blood\u2013brain barrier penetration by dual-targeting doxorubincin liposomes","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","article-title":"pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma","volume":"124","author":"Li","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib72","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.24388","article-title":"Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with aminophenyl-D-manno-pyranoside and folic acid","volume":"104","author":"Kuo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2003.08.006","article-title":"Brain uptake of thiamine-coated nanoparticles","volume":"93","author":"Lockman","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112999_bib74","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.actbio.2020.11.015","article-title":"Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy","volume":"119","author":"Kuo","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2022.112999_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112361","article-title":"Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson's disease treatment","volume":"129","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng.: C"},{"key":"10.1016\/j.colsurfb.2022.112999_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2014.09.015","article-title":"Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-\u03b2 levels in APP\/PS1 transgenic mice","volume":"11","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2015","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib77","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2147\/IJN.S79528","article-title":"Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin","volume":"10","author":"Kuo","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib78","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/IJN.S128396","article-title":"Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer's disease treatment","volume":"12","author":"Kuo","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2020.07.021","article-title":"Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain","volume":"154","author":"Lewicky","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib80","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2147\/IJN.S124276","article-title":"The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/1061186X.2014.965716","article-title":"Targeting delivery of liposomes with conjugated p-aminophenyl-\u03b1-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with \u03b2-amyloid peptide","volume":"23","author":"Kuo","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2015.03.003","article-title":"p-Aminophenyl-\u03b1-d-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain","volume":"188","author":"Singh","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.colsurfb.2022.112999_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2022.112999_bib85","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP\/PS-1 Mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib86","first-page":"1","article-title":"Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19","author":"Naidu","year":"2021","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.colsurfb.2022.112999_bib87","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib88","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.2147\/IJN.S132472","article-title":"Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin","volume":"12","author":"Kuo","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","article-title":"Dual ligand immunoliposomes for drug delivery to the brain","volume":"134","author":"Loureiro","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1 (","key":"10.1016\/j.colsurfb.2022.112999_bib90","doi-asserted-by":"crossref","first-page":"Fso71","DOI":"10.4155\/fso.15.71","article-title":"Immunoliposomes doubly targeted to transferrin receptor and to \u03b1-synuclein","author":"Loureiro","year":"2015","journal-title":"Future Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib91","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model","volume":"39","author":"Thom","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.colsurfb.2022.112999_bib92","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/btpr.2214","article-title":"Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy","volume":"32","author":"Kuo","year":"2016","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.colsurfb.2022.112999_bib93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jtice.2015.12.012","article-title":"Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy","volume":"61","author":"Kuo","year":"2016","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.colsurfb.2022.112999_bib94","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/1061186X.2015.1132223","article-title":"Enhanced delivery of etoposide across the blood\u2013brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles","volume":"24","author":"Kuo","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113211","article-title":"Co-delivery of CPT-11 and panobinostat with anti-GD2 antibody conjugated immunoliposomes for targeted combination chemotherapy","volume":"12","author":"Jose","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2022.112999_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103605","article-title":"Epidermal growth factor (EGF) augments the invasive potential of human glioblastoma multiforme cells via the activation of collaborative EGFR\/ROS-dependent signaling","volume":"21","author":"Pude\u0142ek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42047-020-00060-5","article-title":"The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas","volume":"3","author":"Loureiro","year":"2020","journal-title":"Surg. Exp. Pathol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10517-017-3750-x","article-title":"Internalization of vectorized liposomes loaded with plasmid DNA in C6 glioma cells","volume":"163","author":"Mel'nikov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib99","unstructured":"ClinicalTrials.gov, Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas (GBM-LIPO)."},{"key":"10.1016\/j.colsurfb.2022.112999_bib100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2017.11.026","article-title":"Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells","volume":"269","author":"Kim","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112999_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007197","article-title":"Neuronal PirB upregulated in cerebral ischemia acts as an attractive theranostic target for ischemic stroke","volume":"7","author":"Wang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.colsurfb.2022.112999_bib102","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","article-title":"Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles","volume":"35","author":"Lu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/1061186X.2015.1055569","article-title":"Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes","volume":"24","author":"Cornford","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib104","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib105","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2022.112999_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00278","article-title":"Importance of apolipoprotein A-I in multiple sclerosis","volume":"6","author":"Gardner","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib107","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/26\/49\/495103","article-title":"Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E","volume":"26","author":"Neves","year":"2015","journal-title":"Nanotechnology"},{"key":"10.1016\/j.colsurfb.2022.112999_bib108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-016-0177-x","article-title":"Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E","volume":"14","author":"Neves","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib109","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acs.bioconjchem.6b00705","article-title":"Apo E-functionalization of solid lipid nanoparticles enhances brain drug delivery: uptake mechanism and transport pathways","volume":"28","author":"Neves","year":"2017","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.colsurfb.2022.112999_bib110","first-page":"4267","article-title":"Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain","volume":"9","author":"Tamaru","year":"2014","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib111","series-title":"Nanomedicines for Brain Drug Delivery","first-page":"29","article-title":"Liposomes as brain targeted delivery systems","author":"Lai","year":"2021"},{"key":"10.1016\/j.colsurfb.2022.112999_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barrier in vivo","volume":"10","author":"Stalmans","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2022.112999_bib113","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3390\/molecules24193540","article-title":"Cell-penetrating peptide and transferrin co-modified liposomes for targeted therapy of glioma","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2022.112999_bib114","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2011.09.008","article-title":"Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals","volume":"420","author":"Qin","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.07.021","article-title":"Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery","volume":"419","author":"Qin","year":"2011","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib116","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/1061186X.2011.639022","article-title":"Comparison of four different peptides to enhance accumulation of liposomes into the brain","volume":"20","author":"Qin","year":"2012","journal-title":"J. Drug Target"},{"key":"10.1016\/j.colsurfb.2022.112999_bib117","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S215941","article-title":"Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties","volume":"14","author":"Dos Santos Rodrigues","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib118","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijpharm.2019.06.026","article-title":"Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection","volume":"566","author":"dos Santos Rodrigues","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib119","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.264127","article-title":"Dual-modified liposome for targeted and enhanced gene delivery into mice brain","author":"dos Santos Rodrigues","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.colsurfb.2022.112999_bib120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-013-1242-x","article-title":"Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier","volume":"31","author":"Sharma","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.01.016","article-title":"Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection","volume":"167","author":"Sharma","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112999_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2021.140604","article-title":"Challenge to overcome current limitations of cell-penetrating peptides","volume":"1869","author":"Kim","year":"2021","journal-title":"Biochim. Et Biophys. Acta (BBA) - Proteins Proteom."},{"key":"10.1016\/j.colsurfb.2022.112999_bib123","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1039\/D1RA00550B","article-title":"Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2022.112999_bib124","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2147\/IJN.S157019","article-title":"Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes","volume":"13","author":"Zhao","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/acs.molpharmaceut.9b00848","article-title":"Targeted theranostic of cryptococcal encephalitis by a novel polypyridyl ruthenium complex","volume":"17","author":"Wang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11095-020-02865-1","article-title":"RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s disease","volume":"37","author":"Pinheiro","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2022.112999_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119326","article-title":"Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases","volume":"274","author":"Anthony","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib128","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.colsurfb.2022.112999_bib129","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.colsurfb.2022.112999_bib130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1248\/bpb.b15-00994","article-title":"Preparation of angiopep-2 peptide-modified bubble liposomes for delivery to the brain","volume":"39","author":"Endo-Takahashi","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.colsurfb.2022.112999_bib131","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1080\/09205063.2017.1348739","article-title":"Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification","volume":"28","author":"Han","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib132","first-page":"5995","article-title":"Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells","volume":"10","author":"Bruun","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112999_bib133","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/1061186X.2014.888070","article-title":"Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood\u2013brain barrier in rats","volume":"22","author":"Rip","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2022.112999_bib134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2016.09.003","article-title":"Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo","volume":"20","author":"Maussang","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpb.2019.04.004","article-title":"Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: how can the formulation make a difference?","volume":"139","author":"Hu","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2022.112999_bib136","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jps.23994","article-title":"Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(\u00ae)\/Doxil(\u00ae)--a cerebral open flow microperfusion pilot study","volume":"103","author":"Birngruber","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib137","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/10717544.2018.1519002","article-title":"Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery","volume":"25","author":"Cui","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2022.112999_bib138","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12951-019-0546-3","article-title":"The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB","volume":"17","author":"Formicola","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib139","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/s41380-020-0742-4","article-title":"Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson\u2019s disease","volume":"26","author":"Kahana","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.colsurfb.2022.112999_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111339","article-title":"Enhanced integrin affinity and neural differentiation of induced pluripotent stem cells using Ln5-P4-grafted amphiphilic solid lipid nanoparticles","volume":"118","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng.: C"},{"key":"10.1016\/j.colsurfb.2022.112999_bib141","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dneu.22579","article-title":"Folate action in nervous system development and disease","volume":"78","author":"Balashova","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib142","article-title":"The association between folate and Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib143","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mayocp.2019.01.039","article-title":"Low vitamin B12 and Parkinson disease: potential link to reduced cholinergic transmission and severity of disease","volume":"94","author":"McCarter","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.colsurfb.2022.112999_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080381","article-title":"Formulation strategies for folate-targeted liposomes and their biomedical applications","volume":"11","author":"Kumar","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00207","article-title":"Neurological, psychiatric, and biochemical aspects of thiamine deficiency in children and adults","volume":"10","author":"Dhir","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.colsurfb.2022.112999_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105017","article-title":"Crossing the blood-brain barrier: a review on drug delivery strategies using colloidal carrier systems","volume":"147","author":"Mahringer","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.colsurfb.2022.112999_bib147","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-\u03b21\u201342 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2022.112999_bib148","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nano.2011.06.015","article-title":"Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's A\u03b2 peptide","volume":"7","author":"Taylor","year":"2011","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib149","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.3390\/ijms22157996","article-title":"Improving the utility of a dynorphin peptide analogue using mannosylated glycoliposomes","volume":"22","author":"Lewicky","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.colsurfb.2022.112999_bib151","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2022.112999_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081193","article-title":"Emerging nano-carrier strategies for brain tumor drug delivery and considerations for clinical translation","volume":"13","author":"Lundy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01369","article-title":"Recalcitrant issues and new frontiers in nano-pharmacology","volume":"10","author":"Bhardwaj","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2022.112999_bib154","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2217\/nnm-2019-0402","article-title":"Pereira, Immuno-nanocarriers for brain delivery: limitations from in vitro to preclinical and clinical studies","volume":"15","author":"Loureiro","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2022.112999_bib155","first-page":"480","article-title":"Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances","volume":"14","author":"Niu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112999_bib156","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/pharmaceutics14020224","article-title":"An overview of nanotechnologies for drug delivery to the brain","volume":"14","author":"Ayub","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib158","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/btm2.10004","article-title":"Biomimetic strategies for targeted nanoparticle delivery","volume":"1","author":"Dehaini","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.colsurfb.2022.112999_bib159","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17425247.2018.1444601","article-title":"Selective drug delivery approaches to lesioned brain through blood brain barrier disruption","volume":"15","author":"Al-Ahmady","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2022.112999_bib160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","article-title":"Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery","volume":"15","author":"Battaglia","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2022.112999_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030533","article-title":"Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy-an overview on recent advances","volume":"14","author":"Jacob","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112999_bib162","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","article-title":"Surface modification of lipid-based nanoparticles","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2022.112999_bib163","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40005-021-00548-6","article-title":"Rao, Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches","volume":"52","author":"Hegde","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2022.112999_bib164","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40265-021-01526-w","article-title":"Failed, interrupted, or inconclusive trials on neuroprotective and neuroregenerative treatment strategies in multiple sclerosis: update 2015\u20132020","volume":"81","author":"Huntemann","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.colsurfb.2022.112999_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060542","article-title":"Recent developments in microfluidic technologies for central nervous system targeted studies","author":"Teixeira","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652200683X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652200683X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:51:31Z","timestamp":1778557891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652200683X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":165,"alternative-id":["S092777652200683X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112999","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112999"}}